Cathie Wood's ARK Invest Pivots to AI Stocks, Dumps Genomics Companies
ByAinvest
Tuesday, Jan 27, 2026 7:28 am ET1min read
TEM--
TWST--
TXG--
WRD--
Cathie Wood's ARK Invest sold $2.78 million worth of Twist Bioscience shares on Jan. 26, 2026, while buying $505,380 in Tempus AI stock and $425,653 worth of WeRide shares. The fund also acquired Bullish and Kodiak AI shares, and sold $1.50 million in 10X Genomics stock and $430,741 in Kratos Defense shares. The trades reflect a pivot from biotechnology to artificial intelligence stocks and a reduction in exposure to genomics.

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet